Evidence map›Paper›PMID 40462214›Full record

ArticleJournal of medical case reports2025

Functional improvement by tendon transfer for residual wrist dysfunction after botulinum therapy for severe upper limb spasticity: a case report.

Takatoshi Hara, Yuta Miyazaki, Daisuke Nishida, Naho Takahashi, Keiko Sone, Yuki Hara, Ayano Matsui, Masahiro Abo

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takatoshi HaraDepartment of Physical Rehabilitation, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan. t_hara1019@ncnp.go.jp.
Yuta MiyazakiDepartment of Physical Rehabilitation, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan.
Daisuke NishidaDepartment of Physical Rehabilitation, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan.
Naho TakahashiDepartment of Physical Rehabilitation, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan.
Keiko SoneDepartment of Orthopedic Surgery, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan.
Yuki HaraDepartment of Orthopedic Surgery, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan.
Ayano MatsuiDepartment of Orthopedic Surgery, National Center of Neurology and Psychiatry, National Center Hospital, Tokyo, Japan.
Masahiro AboDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan.

Funding

JSPS KAKENHI JP21K17478Neurological and Psychiatric Disorders of NCNP 5-3
6 · The paper itself

Abstract

backgroundSpasticity is a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes, and hyperactive tendon reflexes, often resulting from upper motor neuron syndrome. Prolonged untreated spasticity can lead to contractures, joint deformities, and pain, significantly impairing activities of daily living. We report a case where a stepwise treatment approach-combining repeated botulinum toxin A, occupational therapy, and tendon transfer surgery-led to significant functional improvement in a patient with severe upper limb spasticity and residual wrist contracture. CASE PRESENTATION: The patient was a 24-year-old Japanese man who underwent surgery for intractable epilepsy as a 7-year-old child and developed left upper limb paralysis after surgery. From the age of 22 years, spasticity worsened, and in addition, the range of motion of the wrist joints became markedly restricted, especially dorsiflexion. Botulinum toxin A therapy was planned and a total of four injections were administered to the left upper limb. Occupational therapy was used in conjunction with the treatment. These treatments reduced spasticity, improved Fugl-Meyer Assessment scores by 2 points, and slightly improved upper extremity function. However, because wrist dorsiflexion restriction remained, additional tendon transfer surgery was performed. This procedure improved his active dorsiflexion of the hand joint to 20°, and 8 weeks after surgery, his Fugl-Meyer Assessment score improved to 52 points. Eventually, the functional use of his left upper limb increased, and he was able to use it to help open and close bottle caps.

conclusionsThis case report demonstrates the successful application of a stepwise treatment approach, combining repetitive botulinum toxin A therapy, occupational therapy, and tendon transfer surgery, for severe upper limb spasticity with residual wrist joint impairments. These findings highlight the importance of tailoring treatment strategies to individual patient characteristics, particularly the presence of residual voluntary muscle activity and the absence of structural joint deformities. This case illustrates the critical role of tendon transfer surgery as a complementary intervention to overcome the limitations of conservative treatments, leading to substantial functional recovery. Future studies should aim to establish clear criteria for selecting candidates for tendon transfer surgery to ensure optimal functional outcomes for patients with severe spasticity.

Indexed as

Botulinum Toxins, Type AContractureMuscle SpasticityNeuromuscular AgentsTendon TransferWrist JointHumansMaleOccupational TherapyRange of Motion, ArticularTreatment OutcomeUpper ExtremityYoung AdultBotulinum Toxins, Type ANeuromuscular AgentsBotulinus toxin A therapyCase reportMotor functionRehabilitationSpasticityUpper limbs

Identifiers

PMID40462214
PMCPMC12131635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.